X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
India: Towards a healthy future? - Views on News from Equitymaster
 
 
  • PRINT
  • E-MAIL
  • FEEDBACK
  • A  A  A
  • Apr 10, 2007

    India: Towards a healthy future?

    The Reserve Bank of India (RBI) Governor, Dr. Y.V. Reddy in his Economic Outlook in March 2007 highlighted the four challenges that the Indian economy faces at present - poor physical infrastructure, fiscal consolidation, agriculture and delivery of essential public services such as education and health. In this write-up, we concentrate on state of affairs in the country's healthcare system and discuss ways to tackle the challenges over a period of time.

    Healthcare services are important to an economy as they play a significant role in reducing the mortality rate and enhancing the quality of life. While much has been said about the poor state of the country's infrastructure, revenues from the healthcare account for 5.2% of the GDP and the sector employs over 4 m people (Source: IBEF). Against this backdrop, the poor state of the health infrastructure in the country, therefore, becomes an important issue that needs to be addressed.

    India's per capita health expenditure in absolute terms is considerably lower in comparison to countries such as China, Brazil, Malaysia, Russia, UK and the US. That said, if we consider the per capita healthcare expenditure (as % of per capita income) the picture is slightly better as can be evinced from the table below:

    India: Low healthcare spending (2004)
    Country Per capita income Per capita health Per capita health expenditure
      (US$) expenditure (US$) as a % of per capita income
    US 39,516 6,103 15.4%
    UK 35,703 2,853 8.0%
    Brazil 3,352 256 7.6%
    China 1,280 70 5.5%
    Russia 3,960 212 5.4%
    India 590 28 4.7%
    Malaysia 4,615 176 3.8%
    Source: World Bank, World Health Organisation

    Pharmaceuticals and hospital services account for 75% of the total healthcare market. The government spending on healthcare (as % of GDP) is as low as 0.9% (In the developed markets of US, UK and Japan the healthcare spend by the government is above 7%). This is abysmal given the fact that the healthcare infrastructure in the country leaves a lot to be desired. This also accounts for the lower life expectancy in India as compared to the developed nations. Some of the issues that need to be addressed are as follows:

    Price control issue: The Indian government is looking to bring more drugs under price control, the main objective being to reduce the prices of medicines in a bid to make them available to the common man. In our view, it is not the price that is an entry-barrier for the common man. India has been a low price market for more than decade now and there has been no tangible benefits. Based on our interaction with pharma companies, there is a pertinent need to invest heavily in rural medical infrastructure, including the quality of medical education institutions, to be able to make a meaningful difference in the long-term.

    Public healthcare scenario: The responsibility of providing healthcare in the country rests with the central, state and local governments. While the public health programmes have been successful in eradicating diseases such as smallpox and reducing the incidence of diseases such as leprosy and polio, the fact of the matter remains that the public sector accounts for 20% to 25% of the total healthcare expenditure (accounting for nearly 1% of GDP).

    This is the lowest in the world and ahead of only five countries namely, Burundi, Myanmar, Pakistan, Sudan and Cambodia (Source: CRISIL). Besides this, public health management is saddled with a host of problems, which include resource crunch, political interference, inflexibility and other bureaucratic roadblocks. As a result, the focus has been increasingly shifting towards private healthcare. While private healthcare is expected to witness major traction in the future, the government needs to also play an active role in improving the quality of healthcare services going forward.

    Hospitals: While the population of India has been on the rise, the growth in healthcare infrastructure has not managed to keep pace with the same. To put things into perspective, there are just 1.1 beds for every 1,000 Indians as compared to around 4.3 in countries such as China, Korea and Thailand, which indicates that huge investments need to be made if the situation has to improve going forward. As per CRISIL, investment of Rs 670 bn will be required by 2011 for ramping up the healthcare infrastructure, of which only one-fifth is expected to come from the government.

    To sum up...

    As compared to the developed world, in India, around 80% of the healthcare payments are borne by individuals out of their own pockets. This percentage stands at around 10% to 30% in the developed markets. This means that increased penetration of health insurance in India will play a critical role in boosting the growth of the healthcare market in the country.

    While the government is planning to increase public spending on health to at least 2% to 3% of GDP over the next five years from the current 0.9%, which is a positive sign, execution of the same remains an issue. At present, of the total healthcare expenditure, around 75% is accounted for by the private sector, which we believe will contribute to the growth of the healthcare market in India in the future. Nevertheless, the government needs to lay increased emphasis on ensuring that medicines and healthcare services are 'accessible' to the country's population at large in the longer term.

     

     

    Equitymaster requests your view! Post a comment on "India: Towards a healthy future?". Click here!

      
     

    More Views on News

    How to Ride Alongside India's Best Fund Managers (The 5 Minute Wrapup)

    Jun 10, 2017

    Forty Indian investing gurus, as worthy of imitation as the legendary Peter Lynch, can help you get rich in the stock market.

    You've Heard of Timeless Books... Ever Heard of Timeless Stocks? (The 5 Minute Wrapup)

    Aug 19, 2017

    Ever heard of Lindy Effect? Find out how you can use it to pick timeless stocks.

    Why NOW Is the WORST Time for Index Investing (The 5 Minute Wrapup)

    Aug 18, 2017

    Buying the index now will hardly help make money in stocks even in ten years.

    Trump Takes a Beating (Vivek Kaul's Diary)

    Aug 18, 2017

    Donald J Trump, a wrasslin' fan, took a 'Holy Sh*t!' blow on Tuesday.

    How To Read Your Mutual Fund Account Statement Correctly (Outside View)

    Aug 17, 2017

    PersonalFN simplifies the mutual fund account statement for you.

    More Views on News

    Most Popular

    Demonetisation Barely Made Any Difference to Tax Collections(Vivek Kaul's Diary)

    Aug 7, 2017

    The data tells us quite a different story from the one the government is trying to project.

    A 'Backdoor' to Multibaggers: It's Like Investing in Asian Paints Ten Years Ago(The 5 Minute Wrapup)

    Aug 10, 2017

    Don't miss these proxy bets on growing companies or in a few years you will be looking back with regret.

    Should You Invest In Bharat-22 ETF? Know Here...(Outside View)

    Aug 8, 2017

    Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...

    Signs of Life in the India VIX(Daily Profit Hunter)

    Aug 12, 2017

    The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

    7 Financial Gifts For Your Sister This Raksha Bandhan(Outside View)

    Aug 7, 2017

    Raksha Bandhan signifies the brother-sister bond. Here are 7 thoughtful financial gifts for sisters...

    More
    Copyright © Equitymaster Agora Research Private Limited. All rights reserved.
    Any act of copying, reproducing or distributing this newsletter whether wholly or in part, for any purpose without the permission of Equitymaster is strictly prohibited and shall be deemed to be copyright infringement.

    LEGAL DISCLAIMER: Equitymaster Agora Research Private Limited (hereinafter referred as 'Equitymaster') is an independent equity research Company. Equitymaster is not an Investment Adviser. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and Equitymaster will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein. Information contained herein does not constitute investment advice or a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual subscribers. Before acting on any recommendation, subscribers should consider whether it is suitable for their particular circumstances and, if necessary, seek an independent professional advice. This is not directed for access or use by anyone in a country, especially, USA or Canada, where such use or access is unlawful or which may subject Equitymaster or its affiliates to any registration or licensing requirement. All content and information is provided on an 'As Is' basis by Equitymaster. Information herein is believed to be reliable but Equitymaster does not warrant its completeness or accuracy and expressly disclaims all warranties and conditions of any kind, whether express or implied. Equitymaster may hold shares in the company/ies discussed herein. As a condition to accessing Equitymaster content and website, you agree to our Terms and Conditions of Use, available here. The performance data quoted represents past performance and does not guarantee future results.

    SEBI (Research Analysts) Regulations 2014, Registration No. INH000000537.

    Equitymaster Agora Research Private Limited. 103, Regent Chambers, Above Status Restaurant, Nariman Point, Mumbai - 400 021. India.
    Telephone: +91-22-61434055. Fax: +91-22-22028550. Email: info@equitymaster.com. Website: www.equitymaster.com. CIN:U74999MH2007PTC175407
     

    Become A Smarter Investor In
    Just 5 Minutes

    Multibagger Stocks Guide 2017
    Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
    We will never sell or rent your email id.
    Please read our Terms

    S&P BSE SENSEX


    Aug 18, 2017 (Close)

    MARKET STATS